| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.44 | $40.05 (0%) | 🛒 Add to cart |
| 120 | $0.37 | $53.39 $44.05 (17%) | 🛒 Add to cart |
| 180 | $0.30 | $80.09 $54.06 (32%) | 🛒 Add to cart |
| 360 | $0.22
Best per pill | $160.18 $79.09 (51%) | 🛒 Add to cart |
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.72 | $43.05 (0%) | 🛒 Add to cart |
| 90 | $0.55 | $64.57 $49.06 (24%) | 🛒 Add to cart |
| 120 | $0.46 | $86.10 $55.06 (36%) | 🛒 Add to cart |
| 180 | $0.38 | $129.15 $68.08 (47%) | 🛒 Add to cart |
| 270 | $0.32 | $193.72 $86.10 (56%) | 🛒 Add to cart |
| 360 | $0.29
Best per pill | $258.30 $104.12 (60%) | 🛒 Add to cart |
| Product dosage: 750mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.97 | $59.07 (0%) | 🛒 Add to cart |
| 60 | $1.38 | $118.14 $83.10 (30%) | 🛒 Add to cart |
| 90 | $1.18 | $177.20 $106.12 (40%) | 🛒 Add to cart |
| 120 | $1.08 | $236.27 $130.15 (45%) | 🛒 Add to cart |
| 180 | $0.98 | $354.41 $177.20 (50%) | 🛒 Add to cart |
| 360 | $0.88
Best per pill | $708.81 $317.36 (55%) | 🛒 Add to cart |
Synonyms | |||
Similar products
More info:
Cipro: Potent Antibacterial Therapy for Bacterial Infections - Evidence-Based Review
Ciprofloxacin, commonly referred to as Cipro, is a broad-spectrum fluoroquinolone antibiotic that has been a cornerstone in treating bacterial infections since its introduction in the 1980s. It’s available in oral tablets, intravenous formulations, and ophthalmic/otic solutions, targeting everything from urinary tract infections to anthrax exposure. The drug works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes critical for DNA replication and transcription. While highly effective, its use requires careful consideration due to potential adverse effects like tendonitis and peripheral neuropathy.
Ciprodex Ophthalmic Solution: Comprehensive Treatment for Ocular Infections with Inflammation - Evidence-Based Review
Ciprodex ophthalmic solution combines two powerful agents – ciprofloxacin, a fluoroquinolone antibiotic, and dexamethasone, a corticosteroid – in a sterile suspension specifically formulated for ocular use. This combination addresses both the infectious component and inflammatory response in various eye conditions, making it particularly valuable in clinical practice where dual-action therapy is indicated. 1. Introduction: What is Ciprodex Ophthalmic Solution? Its Role in Modern Ophthalmology Ciprodex ophthalmic solution represents a significant advancement in ophthalmic therapeutics, combining broad-spectrum antibacterial coverage with potent anti-inflammatory action.
Amoxil: Effective Bacterial Infection Treatment - Evidence-Based Review
Amoxicillin, a broad-spectrum aminopenicillin antibiotic, fundamentally changed how we approach bacterial infections when it first entered clinical practice. I remember my pharmacology professor slamming his hand on the lectern back in ‘98, saying “This is the workhorse, people - don’t overthink it, but don’t underestimate it either.” He was right - amoxicillin’s beta-lactam structure with that extra amino group gives it better oral absorption than plain penicillin, which matters tremendously in real-world patient compliance.
Ciloxan Ophthalmic Solution: Potent Antibacterial Action for Bacterial Conjunctivitis - Evidence-Based Review
Ciloxan ophthalmic solution is a sterile, preservative-free topical antibiotic formulation specifically designed for ocular infections. It contains ciprofloxacin hydrochloride, a broad-spectrum fluoroquinolone, at a concentration equivalent to 0.3% ciprofloxacin. The solution is presented in a 5mL low-density polyethylene bottle with a controlled dropper tip, which is crucial for maintaining sterility and ensuring accurate dosing. Its isotonic, buffered formulation has a pH of approximately 4.5 to minimize stinging upon instillation, though some transient discomfort is still commonly reported.
ciplox
Ciprofloxacin, marketed under brand names like Ciplox, represents a cornerstone in the modern antimicrobial arsenal. As a second-generation fluoroquinolone antibiotic, its development marked a significant advancement in treating challenging bacterial infections. Unlike earlier antibiotics, ciprofloxacin’s broad-spectrum activity and unique mechanism made it invaluable for everything from routine urinary tract infections to life-threatening systemic conditions. I remember first encountering it during my residency in the early 1990s - we’d never seen anything with quite this penetration profile before.
Co-Amoxiclav: Effective Bacterial Infection Treatment - Evidence-Based Review
Co-amoxiclav is a fixed-dose combination antibiotic medication containing amoxicillin trihydrate and clavulanate potassium. It belongs to the penicillin class of antibiotics and is classified as a beta-lactam/beta-lactamase inhibitor combination. The clavulanate component protects amoxicillin from degradation by bacterial beta-lactamase enzymes, significantly expanding its spectrum of activity against beta-lactamase-producing bacteria that would otherwise be resistant to amoxicillin alone. This combination has been a mainstay in clinical practice for decades, particularly valuable for treating mixed infections and those caused by resistant organisms.
Floxin: Potent Broad-Spectrum Antibiotic for Bacterial Infections - Evidence-Based Review
Of course. Here is the comprehensive, evidence-based product monograph for “Floxin,” written in the requested style and format. Floxin, known generically as ofloxacin, is a synthetic fluoroquinolone antibiotic. It represents a significant class of antimicrobial agents developed to combat a wide range of bacterial pathogens. Its introduction marked an advancement in treating complicated infections where other antibiotics had failed or were unsuitable. This monograph provides a comprehensive, evidence-based overview of Floxin, detailing its composition, mechanism, clinical applications, and the critical safety profile that defines its use in contemporary medicine.
Levaquin: Potent Antibacterial Therapy for Resistant Infections - Evidence-Based Review
Levofloxacin, commonly known by its brand name Levaquin, is a synthetic broad-spectrum fluoroquinolone antibiotic. It’s the L-isomer of ofloxacin and represents a significant advancement in antimicrobial therapy due to its enhanced gram-positive coverage while maintaining excellent gram-negative activity. In clinical practice, we’ve moved beyond thinking of it as just another antibiotic—it’s become a workhorse for serious community-acquired and hospital-acquired infections where other agents might fail. 1. Introduction: What is Levaquin? Its Role in Modern Medicine When we first started using Levaquin in the late 90s, it felt like we had a new weapon against the rising tide of resistant pathogens.
levoflox
Levoflox represents one of those interesting cases where the standard pharmaceutical narrative doesn’t quite capture the clinical reality. When we first started working with this fluoroquinolone antibiotic back in the early 2000s, the initial excitement about its broad-spectrum coverage was tempered by some unexpected tendon issues we observed in our orthopedic clinic. The drug itself is the L-isomer of ofloxacin, which gives it that enhanced gram-negative activity while maintaining decent gram-positive coverage, but what really surprised me was how differently patients responded based on their renal function and age.